En Agosto del 2006 dejo de reclutar a Pacientes :
ET-743 in Subjects With Advanced Breast Cancer
This study is no longer recruiting patients.
Sponsors and Collaborators:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
PharmaMar .
Official Title: A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer
Further study details as provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.:
Study start: November 2003
Study ID Numbers: ET743-INT-3
Last Updated: August 14, 2006
********************************************************
El 20 de Septiembre del 2007 se da por concluido :
ET-743 in Subjects With Advanced Breast Cancer
This study has been completed.
Sponsors and Collaborators: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. . PharmaMar
Official Title: A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer
Further study details as provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.:
Study start: November 2003
Study ID Numbers: ET743-INT-3
Last Updated: September 20, 2007